Back
Novo Nordisk AS Stock Price Chart

Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
50
NONOF
Novo Nordisk AS
Last Price:
$68.87
Seasonality Move:
4.94%
7 Day Trial
ALL ACCESS PASS
$
7

The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
The current trend is relatively stagnant and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
Novo Nordisk AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.65 | Buy |
20-day SMA: | 66.33 | Buy |
50-day SMA: | 66.98 | Buy |
200-day SMA: | 96.37 | Sell |
8-day EMA: | 67.2 | Buy |
20-day EMA: | 66.26 | Buy |
50-day EMA: | 68.88 | Buy |
200-day EMA: | 89.18 | Sell |
Novo Nordisk AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 60.41 | Buy |
Chaikin Money Flow: | 27823 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.85 - 67.87) | Buy |
Bollinger Bands (100): | (65.78 - 85.44) | Sell |
Novo Nordisk AS Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 71.25 while NONOF 8-day simple moving average is 66.65, which is a Buy signal.
-
The stock price of NONOF is 71.25 while Novo Nordisk AS 20-day SMA is 66.33, which makes it a Buy.
-
Novo Nordisk AS 50-day simple moving average is 66.98 while NONOF share price is 71.25, making it a Buy technically.
-
NONOF stock price is 71.25 and Novo Nordisk AS 200-day simple moving average is 96.37, creating a Sell signal.
NONOF Technical Analysis vs Fundamental Analysis
Sell
50
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a SellThe current Novo Nordisk AS [NONOF] share price is $71.25. The Score for NONOF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
316.6B
Price in USD:
71.25
Share Volume:
47.1K
Novo Nordisk AS 52-Week Range
52-Week High:
149.55
52-Week Low:
55.28
Sell
50
Novo Nordisk AS (NONOF)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?The Novo Nordisk AS stock price is 71.25 USD today.
-
Will NONOF stock go up or go down?Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 71.25 while NONOF 8-day exponential moving average is 67.20, which is a Buy signal.
-
The stock price of NONOF is 71.25 while Novo Nordisk AS 20-day EMA is 66.26, which makes it a Buy.
-
Novo Nordisk AS 50-day exponential moving average is 68.88 while NONOF share price is 71.25, making it a Buy technically.
-
NONOF stock price is 71.25 and Novo Nordisk AS 200-day simple moving average is 89.18, creating a Sell signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
-
NONOF Moving Average Covergence Divergence (MACD) indicator is 0.29, suggesting Novo Nordisk AS is a Buy
-
Novo Nordisk AS Relative Strength Index (RSI) is 60.41, which suggest Novo Nordisk AS is overbought
-
The Bollinger Bands (25) for Novo Nordisk AS is (62.85 - 67.87), which suggest Novo Nordisk AS is a Sell
-
The Bollinger Bands (100) for Novo Nordisk AS is (65.78 - 85.44), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.